Clough Capital Partners L P Buys Shares of 229,127 Acadia Healthcare Company, Inc. $ACHC

Clough Capital Partners L P purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the first quarter, HoldingsChannel.com reports. The firm purchased 229,127 shares of the company’s stock, valued at approximately $5,359,000.

Several other hedge funds have also recently added to or reduced their stakes in ACHC. EverSource Wealth Advisors LLC boosted its holdings in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after buying an additional 497 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Acadia Healthcare by 208.9% in the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares during the period. Bayforest Capital Ltd acquired a new stake in shares of Acadia Healthcare in the 4th quarter valued at approximately $52,000. GAMMA Investing LLC boosted its stake in Acadia Healthcare by 124.7% during the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after acquiring an additional 2,698 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its holdings in Acadia Healthcare by 4,264.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 5,325 shares of the company’s stock valued at $76,000 after purchasing an additional 5,203 shares during the period.

Acadia Healthcare Price Performance

ACHC stock opened at $34.51 on Monday. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The stock has a market capitalization of $3.17 billion, a P/E ratio of -2.82, a P/E/G ratio of 11.51 and a beta of 0.64. Acadia Healthcare Company, Inc. has a fifty-two week low of $11.43 and a fifty-two week high of $35.83. The business has a 50-day moving average of $27.64 and a 200-day moving average of $23.24.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. During the same quarter last year, the firm earned $0.40 EPS. Acadia Healthcare’s revenue for the quarter was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on ACHC shares. KeyCorp upped their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Royal Bank Of Canada boosted their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective for the company in a research report on Monday, May 4th. Guggenheim increased their price target on Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $28.69.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.